SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001213900-21-002380
Filing Date
2021-01-15
Accepted
2021-01-15 06:13:55
Documents
37

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs42021a4_fsdevelopment.htm S-4/A 14358245
2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF G fs42021a4ex23-2_fsdevelop.htm EX-23.2 1761
3 GRAPHIC timage_001.jpg GRAPHIC 248715
  Complete submission text file 0001213900-21-002380.txt   16663766

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE fsdc-20200930.xml EX-101.INS 322749
5 XBRL SCHEMA FILE fsdc-20200930.xsd EX-101.SCH 32526
6 XBRL CALCULATION FILE fsdc-20200930_cal.xml EX-101.CAL 19689
7 XBRL DEFINITION FILE fsdc-20200930_def.xml EX-101.DEF 149186
8 XBRL LABEL FILE fsdc-20200930_lab.xml EX-101.LAB 256294
9 XBRL PRESENTATION FILE fsdc-20200930_pre.xml EX-101.PRE 154105
Mailing Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111
Business Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111 (415) 877-4887
FS Development Corp. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-249785 | Film No.: 21530471
SIC: 2834 Pharmaceutical Preparations